# FDA Inspection 1167160 - Peter Charles Klatsky, M.D., Inc. - April 11, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/peter-charles-klatsky-md-inc/0bbd4437-3d59-49b6-924b-042d2786b72c
Source feed: FDA_Inspections

> FDA Inspection 1167160 for Peter Charles Klatsky, M.D., Inc. on April 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167160
- Company Name: Peter Charles Klatsky, M.D., Inc.
- Inspection Date: 2022-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1270885 - 2025-05-16](https://www.globalkeysolutions.net/records/fda_inspections/peter-charles-klatsky-md-inc/0c75c4cd-380c-4248-9e35-48f5eed9ed23)
- [FDA Inspection 1270885 - 2025-05-16](https://www.globalkeysolutions.net/records/fda_inspections/peter-charles-klatsky-md-inc/b2fc599e-d48c-4c18-8d6f-cd1864ae3f55)
- [FDA Inspection 1167160 - 2022-04-11](https://www.globalkeysolutions.net/records/fda_inspections/peter-charles-klatsky-md-inc/daa53203-eefe-4220-b8bf-54b47dca07f2)

Company: https://www.globalkeysolutions.net/companies/peter-charles-klatsky-md-inc/e51be983-ee3f-46e6-8d32-f8e9c720ba63

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d